Asia Green Biotechnology (XCNQ:ASIA) Shares Outstanding (EOP): 36.25 Mil (As of Sep. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Asia Green Biotechnology Shares Outstanding (EOP)?

Asia Green Biotechnology XCNQ:ASIA Shares Outstanding (EOP) is 36.25 Mil as of Sep. 2024.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Asia Green Biotechnology's shares outstanding for the quarter that ended in Sep. 2024 was 36.25 Mil.

Asia Green Biotechnology's quarterly shares outstanding stayed the same from Jun. 2024 (36.25 Mil) to Sep. 2024 (36.25 Mil).

Asia Green Biotechnology's annual shares outstanding stayed the same from Dec. 2022 (36.25 Mil) to Dec. 2023 (36.25 Mil).


Asia Green Biotechnology  (XCNQ:ASIA) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Asia Green Biotechnology Shares Outstanding (EOP) Related Terms


Asia Green Biotechnology Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Asia Green Biotechnology's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asia Green Biotechnology Shares Outstanding (EOP) Chart

Asia Green Biotechnology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
Get a 7-Day Free Trial 36.25 36.25 36.25 36.25 36.25

Asia Green Biotechnology Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.25 36.25 36.25 36.25 36.25

XCNQ:ASIA vs ZTS: Shares Outstanding (EOP) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Asia Green Biotechnology's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asia Green Biotechnology Shares Outstanding (EOP) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Asia Green Biotechnology's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Asia Green Biotechnology's Shares Outstanding (EOP) falls into.



Asia Green Biotechnology Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 36.25 Mil mean?
Asia Green Biotechnology (XCNQ:ASIA) has a Shares Outstanding (EOP) of 36.25 Mil as of Sep. 2024. The total shares a company has outstanding, at period-end. View historical data on Asia Green Biotechnology and its competitors.
Is Asia Green Biotechnology's Shares Outstanding (EOP) too high?
Asia Green Biotechnology's current Shares Outstanding (EOP) is 36.25 Mil.
How does Asia Green Biotechnology's Shares Outstanding (EOP) compare to ZTS?
Asia Green Biotechnology's Shares Outstanding (EOP) of 36.25 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Drug Manufacturers company?
A good Shares Outstanding (EOP) depends on the Drug Manufacturers industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Asia Green Biotechnology and its competitors. Asia Green Biotechnology's current Shares Outstanding (EOP) is 36.25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asia Green Biotechnology stock overvalued right now?
Asia Green Biotechnology (XCNQ:ASIA) has a current Shares Outstanding (EOP) of 36.25 Mil. The current Shares Outstanding (EOP) is 36.25 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Asia Green Biotechnology (XCNQ:ASIA), the current Shares Outstanding (EOP) is 36.25 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Asia Green Biotechnology Business Description

Address 707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
Asia Green Biotechnology Corp is an early stage international agri-technology company focused on the development, evaluation, testing, application and, ultimately, supply to the market of proprietary organic hybridization technology and certain products derived from that technology. The core approach of the business is centred on the planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities. The company is developing varieties of hemp with superior growth and production characteristics in the various environments found in the licensed territories.